ajinomoto co., inc....supplementary results materials will be published on the company’s website...
TRANSCRIPT
1
Ajinomoto Co., Inc.
Consolidated Results
IFRS
First Half Ended September 30, 2020
This document has been translated from the original Japanese as a guide for non-Japanese investors. It contains forward-looking statements based on a number of assumptions and judgements made by management in light of information currently available. Actual financial results may differ depending on a number of factors, including changing economic conditions, legislative and regulatory developments, delay in new product launches, and pricing and product initiatives of competitors.
2
SUMMARY OF FINANCIAL STATEMENTS [IFRS] (Consolidated)
First half results for the fiscal year ending March 31, 2021
Ajinomoto Co., Inc. November 4, 2020 Stock Code: 2802 Stock exchange listing: Tokyo Stock Exchange URL: https://www.ajinomoto.co.jp/company/ President: Takaaki Nishii For inquiries: Eiichi Mizutani Telephone: +81-3-5250-8111 General Manager Global Finance Department
Scheduled date of submission of statutory quarterly financial report: November 10, 2020
Scheduled date of payment of dividend: December 4, 2020
Creation of supplementary results materials for quarterly financial report: Yes
Quarterly results briefing: Yes (for analysts)
“Change %” indicates the percentage change compared to the same period of the previous fiscal year.
Note 1: Upon the adoption of IFRS, the Ajinomoto Group has introduced “business profit” as a new profit level that will better enable
investors, the Board of Directors, and the Management Committee to grasp the core business results and future outlook of each
business while also facilitating continuous evaluation of the Group’s business portfolio by the Board of Directors and the
Management Committee. “Business profit” is defined as sales minus the cost of sales, selling expenses, research and development
expenses, and general and administrative expenses, to which is then added share of profit of associates and joint ventures.
Business profit does not include other operating income or other operating expenses. Note 2: In the fiscal year ended March 31, 2020, the Ajinomoto Group was classified the packaging business under discontinued
operations. Together with the logistics business, which had been previously classified under discontinued operations, profit from discontinued operations in the condensed quarterly consolidated statements is presented separately from the profit from continuing operations, and sales, business profit, and profit before income taxes are amounts related to continuing operations. Amounts shown for the corresponding period of the fiscal year ended March 31, 2020 have been adjusted to reflect this change; accordingly, the percent change from the previous year’s results is not shown.
Note 3: In the previous fiscal year, the Company finalized a provisional accounting treatment related to a business combination. The figures for the first half ended September 30, 2019 have been adjusted to reflect the finalization of the provisional accounting treatment.
(2) Consolidated Financial Position
Millions of yen, rounded down
As of September 30, 2020
As of March 31, 2020
Total assets ..................................................................... 1,331,220 1,353,616 Total equity ...................................................................... 608,698 592,070 Equity attributable to owners of the parent company ....... 565,099 538,975 Ownership ratio attributable to owners of the parent company (%) .................................................................... 42.4% 39.8%
1. Consolidated Financial Results for the First Half Ended September 30, 2020
(1) Consolidated Operating Results
Millions of yen, rounded down
First half ended September 30, 2020
First half ended September 30, 2019
Change % Change % Sales ............................................................................. 511,382 (3.9) 532,266 — Business profit .............................................................. 61,940 30.0 47,654 — Profit before income taxes ............................................ 59,954 185.6 20,992 — Profit ............................................................................. 41,106 234.4 12,294 — Profit attributable to owners of the parent company ...... 36,661 420.1 7,049 — Basic earnings per share (yen) ....................................... ¥66.87 — ¥12.86 — Diluted earnings per share (yen) .................................... ¥66.84 — — —
3
Note: Revisions to dividend forecasts in the period under review: None
“Change %” indicates the percentage change compared to the previous fiscal year. Notes: Revisions to forecasts in the period under review: Yes Please refer to Notice of Revisions to Full-Year Consolidated Performance Forecast for the Fiscal Year Ending March 31, 2021 released today (November 4, 2020) for more details about the revision of the consolidated results forecast.
2. Dividends
Millions of yen, rounded down
Fiscal year ended
March 31, 2020
Fiscal year ending
March 31, 2021
Fiscal year ending
March 31, 2021
(forecast)
Dividend per share
Interim (yen) ....................................................... ¥16.00 ¥16.00
Year-end (yen) .................................................... ¥16.00 ¥16.00
Annual (yen) ....................................................... ¥32.00 ¥32.00
3. Forecast for the Fiscal Year Ending March 31, 2021
Millions of yen, rounded down
Fiscal year ending March 31, 2021
Change %
Sales ................................................................................. 1,066,000 (3.1)
Business profit .................................................................. 100,000 0.8
Profit attributable to owners of the parent company .......... 36,000 91.1
Basic earnings per share (yen) ......................................... 65.65 —
4
Notes:
(1) Changes in significant subsidiaries during the period (Changes in specified subsidiaries resulting in the change
in consolidation scope): None
(2) Changes in accounting policies and accounting estimates
1) Changes in accounting policies as required by IFRS: Yes
2) Other changes in accounting policies: None
3) Changes in accounting estimates: None
(3) Number of shares outstanding (ordinary shares)
Shares
As of September 30, 2020 As of March 31, 2020
Number of shares outstanding at end of period (including treasury shares):
549,163,354 549,163,354
Number of treasury shares at end of period 817,311 974,103
April 1, 2020 to September 30, 2020 April 1, 2019 to September 30, 2019
Average number of shares during period 548,211,212 548,106,993
(Note) The number of treasury shares at the end of the period includes the Company’s shares held by “Director’s
remuneration BIP Trust” (As of September 30, 2020: 715,500 shares. As of March 31, 2020: 873,700 shares),
which has been adopted along with the introduction of Stock-based Remuneration of Executive Officers Based on
the Company’s Medium-term Earnings Performance for the Directors and others. In addition, these Company’s
shares are included in the treasury shares which are deducted from the number of shares when calculating the
average number of shares during the period.
Summary quarterly financial statements are exempted from review by a public certified accountant or an auditing firm.
Appropriate use of forecasts and other notes
Disclaimer regarding forward-looking statements and other information
Forward-looking statements, such as business forecasts, included in this document are based on management’s
estimates, assumptions, and projections at the time of publication. These statements do not represent a promise or
commitment by the Company to achieve these forecasts. Actual operating results may differ significantly due to
various factors. For more information regarding our earnings forecasts, see page 6, “1. Qualitative Information on
First Half Consolidated Results, (1) Overview of Operating Results.”
Method of obtaining supplementary results materials
Supplementary results materials will be published on the Company’s website on Wednesday, November 4, 2020.
5
Table of contents
1 Qualitative Information on First Half Consolidated Results ............................................................................... 6
(1) Overview of Operating Results ................................................................................................................. 6
(2) Overview of Financial Position .................................................................................................................. 10
2 Condensed Consolidated Financial Statements and Notes .............................................................................. 11
(1) Condensed Consolidated Statements of Financial Position ..................................................................... 11
(2) Condensed Consolidated Statements of Income ..................................................................................... 13
First Half ................................................................................................................................................. 13
(3) Notes to Condensed Consolidated Financial Statements ........................................................................ 14
Going Concern Assumption ...................................................................................................................... 14
Significant Accounting Policies ................................................................................................................. 14
Segment Information ................................................................................................................................. 14
6
1. Qualitative Information on First Half Consolidated Results
Upon the adoption of IFRS, the Ajinomoto Group introduced "business profit” as a new profit level that will
better enable investors, the Board of Directors, and the Management Committee to grasp the core business
results and future outlook of each business while also facilitating continuous evaluation of the Group’s
business portfolio by the Board of Directors and the Management Committee. “Business profit” is defined as
sales minus the cost of sales, selling expenses, research and development expenses, and general and
administrative expenses, to which is then added share of profit of associates and joint ventures. Business
profit does not include other operating income or other operating expenses.
On February 5, 2020, the Ajinomoto Group entered into a contract to transfer the entire equity stake held
by the Group corresponding to 51% of the outstanding shares in Fuji Ace Co., Ltd., a packaging materials
manufacturing and sales company in Thailand, to Fuji Seal International, Inc. and other entities, and
transferred the equity stake on March 6, 2020.
Accordingly, profit related to the packaging business in the first half of the fiscal year ended March 31,
2020 has been restated as profit from discontinued operations, and the discontinued operations have been
presented separately from continuing operations.
In the previous fiscal year, the Company finalized a provisional accounting treatment related to a business
combination. Accordingly, a significant revision has been made in the initial allocation of acquisition costs for
the first half ended September 30, 2019.
(1) Overview of Operating Results
In the first half, ended September 30, 2020, the Company’s consolidated sales fell 3.9% year-on-year, or
¥20.8 billion, to ¥511.3 billion. This was because there was a continued decline in sales in conjunction with the
COVID-19 global pandemic, mainly in Seasonings and Foods and Frozen Foods, even though a trend of
recovery can be seen in demand for products for use in foodservice while sales of home-use products
increased due to the expansion in at-home dining demand. Business profit increased 30% year-on-year, or
¥14.2 billion to ¥61.9 billion, owing to the effect of increased sales of home-use products and lower expenses
due to a reduction in marketing and associated activities in Seasonings and Foods and Frozen Foods during
the lockdown and stay-at-home periods, and a large increase in profit for animal nutrition products in addition
to other factors including the effect of recording impairment loss related to the trademark rights of Promasidor
Holdings Limited (“PH”) in the same period of the previous year. Profit attributable to owners of the parent
company totaled ¥36.6 billion, up 420.1% year-on-year, or ¥29.6 billion. The reasons for the increase were
mainly the effect of recording impairment losses on investments accounted for using the equity method
related to PH, and on production equipment in the animal nutrition business and the bakery business in the
same period of the previous year.
Furthermore, the Company has revised the financial results forecast announced on July 30, 2020 based
on recent progress in business performance in the first half of this fiscal year.
The Company has increased the forecast for sales by ¥9.0 billion from the previous forecast to ¥1,066.0
billion. This is largely because in Seasonings and Foods and Frozen Foods accompanying the COVID-19
global pandemic, sales of home-use products are expected to exceed the previous forecast due to the
increase in at-home dining demand, although sales of products for use in foodservice are expected to remain
lower than in the previous year despite a trend of recovery, and the revision of the forecast is the result of
reviewing the impact of these factors in the current environment. The percentage of progress of sales against
the revised forecast is 48.0%. Business profit is expected to exceed the previous forecast, mainly due to sales
growth, improved profitability, and reductions in expenses for electronic materials and amino acids for
pharmaceuticals and foods in the Healthcare and Others segment in addition to sales growth of seasonings
and frozen foods, improved profitability due to the product mix and other factors, and reductions in expenses
in the Seasonings and Foods and Frozen Foods segments. As a result, the Company has increased the
forecast for business profit by ¥10.0 billion from the previous forecast to ¥100.0 billion. The percentage of
progress of business profit against the revised forecast is 61.9%. The Company has also increased the
forecast for profit attributable to owners of the parent company by ¥4.0 billion from the previous forecast to
7
¥36.0 billion given the revision of business profit. The percentage of progress of profit attributable to owners of
the parent company against the revised forecast is 101.8%.
Please also refer to Notice of Revision to Full-Year Consolidated Performance Forecast for the Fiscal Year
Ending March 31, 2021 released today (November 4, 2020) for more details about the revision of the
consolidated results forecasts.
Consolidated operating results by segment
Results for individual business segments are summarized below.
Billions of yen, rounded down
YoY Sales YoY change
- amount YoY change
- percent Business
profit YoY change
- amount YoY change
- percent
Seasonings and
Foods 295.3 (12.9) (4.2) % 47.0 8.3 21.7 %
Frozen Foods 98.8 (4.4) (4.3) % 2.6 1.3 96.0 %
Healthcare and
Others 110.6 (2.9) (2.6) % 11.9 4.7 67.1 %
Other 6.5 (0.5) (7.7) % 0.2 (0.2) (47.3) %
Total 511.3 (20.8) (3.9) % 61.9 14.2 30.0 %
Billions of yen, rounded down
Sales Business profit
Vs. the forecast FY2020 first half
Forecast for the year
Achieved - percent
FY2020 first half
Forecast for the year
Achieved - percent
Seasonings and
Foods 295.3 615.3 48.0 % 47.0 76.3 61.7 %
Frozen Foods 98.8 205.0 48.2 % 2.6 0.5 466.3 %
Healthcare and
Others 110.6 229.6 48.2 % 11.9 22.2 53.8 %
Other 6.5 15.9 41.0 % 0.2 0.8 27.7 %
Total 511.3 1,066.0 48.0 % 61.9 100.0 61.9 %
8
1) Seasonings and Foods
In the Seasonings and Foods segment, sales fell 4.2% year-on-year, or ¥12.9 billion, to ¥295.3 billion, largely
because of lower sales of products for foodservice owing to lower demand for foodservice products, despite
increased sales of home-use products due to higher at-home dining demand. Segment business profit
increased 21.7% year-on-year, or ¥8.3 billion, to ¥47.0 billion, owing to the effect of increased sales of home-
use products and lower marketing expenses in addition to the recording of impairment loss related to
trademark rights of PH and other factors in the same period of the previous year.
Main factors affecting segment sales
Sauce & Seasonings: Decrease in revenue due to the impacts of
currency translation and decreased sales of foodservice-use products
overseas from decreased demand, despite increased sales in home-
use products accompanying increased at-home demand.
In Japan, revenue increased due to strong sales of home-use
products.
Overseas, revenue decreased due to the impacts of currency
translation and decreased sales for foodservice-use products, despite
increased revenue of menu-specific seasonings.
Quick Nourishment: Decrease in revenue due to decreased sales of
overseas products and restaurant and industrial-use coffee products,
despite higher year-on-year sales in Japan of home-use products due
to increased at-home demand.
In Japan, revenue decreased due to decreased sales of restaurant and industrial-use coffee products,
despite higher year-on-year sales in home-use coffee products and soup.
Overseas, revenue decreased due to the impacts of currency translation and decreased sales of
instant noodles and beverages.
Solution & Ingredients: Decrease in revenue due to decreased sales of foodservice-use products in
Japan from decreased demand and decreased revenue from umami seasonings for processed food
manufacturers.
Main factors affecting segment profits
Sauce & Seasonings: Large increase in profit due to the effect of
increased revenue from home-use products and decreased marketing
expenses.
In Japan, large increase in profit due to the effect of increased
revenue and decreased marketing expenses.
Overseas, large increase in profit due to decreased marketing
expenses and the effect of improvement in the product mix, despite
the impact of currency translation.
Quick Nourishment: Large increase in profit due to a previous-year
impairment loss on trademark rights of Promasidor Holdings
(hereinafter, PH) and the effect of increased revenue from home-use
products in Japan.
In Japan, a large increase in profit due to the effect of increased revenue from major home-use coffee
products and decreased marketing expenses.
Overseas, a large increase in profit due to the previous-year impairment loss on trademark rights of
PH, despite the effect of decreased revenue.
Solution & Ingredients: Large decrease in profit due to the effect of decreased revenue from
foodservice-use products in Japan and umami seasonings for processed food manufacturers.
9
2) Frozen Foods
Frozen Foods segment sales fell 4.3% year-on-year, or ¥4.4 billion, to ¥98.8 billion, as the result of a
decline in sales of restaurant-use products due to lower foodservice demand despite increased sales of
home-use products due to higher home cooking demand. Segment business profit had a significant
increase of 96.0% year-on-year or ¥1.3 billion, to ¥2.6 billion, mainly owing to the effect of increased sales
of home-use products and lower marketing expenses.
Main factors affecting segment sales
Decrease in revenue due to decreased sales of restaurant-use
products because of decreased demand for foodservices, despite
increased sales of home-use accompanying increased at-home
demand.
In Japan, revenue decreased due to decreased sales of restaurant-
use products, despite increased sales of major home-use products,
primarily Gyoza.
Overseas, despite North American sales basically level with the
previous year on a local currency base, overall revenue decreased
due to the impacts of currency translation and decreased sales of
restaurant-use products.
Main factors affecting segment profits
Large increase in profit due to the effect of increased revenue from
home-use products and decreased marketing expenses.
In Japan, a large increase in profit due to the effect of increased
revenue from major home-use products and decreased marketing
expenses.
Overseas, increased profit due to the effect of increased revenue from
home-use products and decreased marketing expenses.
10
3) Healthcare and Others
Healthcare and Others segment sales decreased 2.6% year-on-year, or ¥2.9 billion, to ¥110.6 billion, owing
to a large decrease in animal nutrition and sports nutrition sales despite a significant increase in sales of
specialty chemicals. Segment business profit increased 67.1% year-on-year, or ¥4.7 billion, to ¥11.9 billion
accompanying large increases in profit for animal nutrition products and specialty chemicals.
Main factors affecting segment sales
Amino Acids: Decrease in revenue due to the timing of shipments in
Bio-Pharma Services.
Specialty chemicals: Large increase in revenue primarily due to strong
sales of electronic materials.
Others: Decrease in revenue due to a decrease in sales volume of
animal nutrition and a decrease in demand for sports nutrition
products.
Main factors affecting segment profits
Amino Acids: Decreased profit due to the effects of the Bio-Pharma
Services product mix.
Specialty chemicals: Large increase in profit accompanying large
increase in revenue.
Others: Large increase in profit due to increased unit sales prices in
animal nutrition.
4) Other
In the Other segment, sales totaled ¥6.5 billion, down 7.7% year-on-year, or ¥0.5 billion. Segment
business profit totaled ¥0.2 billion, a decrease of 47.3% year-on-year, or ¥0.2 billion.
(2) Overview of Financial Position
As of September 30, 2020, the Company’s consolidated total assets stood at ¥1,331.2 billion, a decrease of
¥22.3 billion from ¥1,353.6 billion at the end of the previous fiscal year on March 31, 2020. The main reason
for this decrease is a decrease in trade and other receivables.
Total liabilities came to ¥722.5 billion, ¥39.0 billion less than the ¥761.5 billion at the end of the previous
fiscal year, mainly due to a decrease in trade and other payables. Interest-bearing debt totaled ¥419.6 billion,
an increase of ¥5.9 billion from the end of the previous fiscal year, mainly due to an increase in short-term
borrowings although commercial papers and current portion of bonds decreased.
Total equity as of September 30, 2020 was ¥16.6 billion more than at the end of the previous fiscal year,
mainly reflecting an increase in retained earnings. Equity attributable to owners of the parent company, which
is total equity minus noncontrolling interests, totaled ¥565.0 billion, and the equity ratio attributable to owners
of the parent company was 42.4%.
11
2. Condensed Consolidated Financial Statements and Notes
(1) Condensed Consolidated Statements of Financial Position
Millions of yen
As of end of first half
(September 30, 2020)
As of end of previous fiscal
year (March 31, 2020)
Assets
Current assets
Cash and cash equivalents 141,857 141,701
Trade and other receivables 160,197 184,739
Other financial assets 10,506 8,946
Inventories 193,169 178,636
Income taxes receivable 3,584 8,653
Others 16,635 16,225
Sub total 525,951 538,901
Assets of disposal groups classified as held for sale — —
Total current assets 525,951 538,901
Non-current assets
Property, plant and equipment 459,908 454,357
Intangible assets 69,261 69,245
Goodwill 89,983 89,964
Investments in associates and joint ventures 111,417 116,280
Long-term financial assets 51,453 50,132
Deferred tax assets 11,994 17,781
Others 11,250 16,952
Total non-current assets 805,269 814,714
Total assets 1,331,220 1,353,616
12
Millions of yen
As of end of first half
(September 30, 2020) As of end of previous fiscal
year (March 31, 2020)
Liabilities
Current liabilities
Trade and other payables 156,752 178,583
Short-term borrowings 48,082 8,043
Commercial papers 4,000 40,000
Current portion of bonds — 19,995
Current portion of long-term borrowings 14,645 15,191
Other financial liabilities 6,740 5,401
Short-term employee benefits 36,588 41,588
Provisions 3,206 5,272
Income taxes payable 9,506 12,517
Others 8,892 8,972
Sub total 288,415 335,566
Liabilities of disposal groups classified as held
for sale — —
Total current liabilities 288,415 335,566
Non-current liabilities
Corporate bonds 149,579 149,550
Long-term borrowings 147,342 124,135
Other financial liabilities 70,503 72,738
Long-term employee benefits 55,702 66,659
Provisions 5,489 7,264
Deferred tax liabilities 4,383 4,503
Others 1,105 1,127
Total non-current liabilities 434,105 425,978
Total liabilities 722,521 761,545
Equity
Common stock 79,863 79,863
Capital surplus (7,271) —
Treasury stock (1,809) (2,160)
Retained earnings 602,229 574,287
Other components of equity (107,912) (113,015)
Disposal groups classified as held for sale — —
Equity attributable to owners of the parent
company 565,099 538,975
Non-controlling interests 43,598 53,095
Total equity 608,698 592,070
Total liabilities and equity 1,331,220 1,353,616
13
(2) Condensed Consolidated Statements of Income
Millions of yen
First half (April 1, 2020 to
September 30, 2020)
First half (April 1, 2019 to
September 30, 2019)
Continuing operations
Sales 511,382 532,266
Cost of sales (315,213) (337,451)
Gross profit 196,168 194,814
Share of profit of associates and joint ventures 1,786 (1,808)
Selling expenses (71,220) (82,731)
Research and development expenses (12,337) (13,882)
General and administrative expenses (52,456) (48,737)
Business profit 61,940 47,654
Other operating income 6,134 2,721
Other operating expenses (6,772) (29,616)
Operating profit 61,302 20,759
Financial income 1,585 3,628
Financial expenses (2,933) (3,395)
Profit before income taxes 59,954 20,992
Income taxes (18,848) (8,503)
Profit from continuing operations 41,106 12,489
Profit (loss) from discontinued operations — (195)
Profit 41,106 12,294
Profit Attributable to:
Owners of the parent company 36,661 7,049
Non-controlling interests 4,445 5,244
Profit from continuing operations attributable to owners of the
parent company
36,661 7,409
Profit from discontinued operations attributable to owners of the
parent company
— (359)
Profit attributable to owners of the parent company 36,661 7,049
Earnings per share from continuing operations (yen):
Basic 66.87 13.52
Diluted 66.84 —
Earnings per share from discontinued operations (yen):
Basic — (0.66)
Diluted — —
Earnings per share (yen):
Basic 66.87 12.86
Diluted 66.84 —
14
(3) Notes to Condensed Consolidated Financial Statements
Going Concern Assumption
Not applicable
Significant Accounting Policies
With the exception of the items explained below, the significant accounting policies used to prepare these
condensed consolidated financial statements for the first half are unchanged from the policies applied to the
consolidated financial statements in the previous fiscal year.
Income taxes for this first half are calculated based on an estimation of the effective tax rate for the fiscal year.
Impact of Applying New Accounting Policies
The Group has applied the following accounting standards from the first quarter of this fiscal year.
IFRS Overview of new standards or amendments
IFRS 7 Financial Instruments: Disclosures Partial amendment of hedge accounting
requirements in response to IBOR reform IFRS 9 Financial Instruments
At the present stage, there is no impact due to applying the above accounting standards.
Segment Information
1) Overview of reportable segments
The Group’s reportable segments are categorized primarily by product lines. From the first quarter of this fiscal year,
the Group has reclassified its previous four reportable segments of Japan Food Products, International Food
Products, Life Support, and Other into three reportable segments: Seasonings and Foods, Frozen Foods, and
Healthcare and Others. This reclassification accompanies changes in corporate organization aimed at strengthening
business-based global management systems for the core businesses in the Medium-Term Management Plan.
Each reportable segment is a component of the Group for which separate financial information is available and
evaluated regularly by the Management Committee in determining the allocation of management resources and in
assessing performance.
Segment information for the first half of the fiscal year ended March 31, 2020 discloses information prepared
based on the reportable segment classifications after the changes in corporate organization.
In addition, in the fiscal year ended March 31, 2020, the packaging business was classified under discontinued
operations, and segment information presents amounts related to continuing operations only, excluding the packaging
business.
In the previous fiscal year, the Company finalized a provisional accounting treatment related to a business
combination. Accordingly, a significant revision has been made in the initial allocation of acquisition costs for the first
half, ended September 30, 2019.
15
The product categories belonging to each reportable segment are as follows:
Reportable
Segments Details Main Products
Seasonings
and Foods
Sauce and
Seasonings
Umami seasonings AJI-NO-MOTO®, HON-DASHI®, Cook Do®,
Ajinomoto KK Consommé, Pure Select® Mayonnaise,
Ros Dee® (flavor seasoning/Thailand), Masako® (flavor
seasoning/Indonesia), Aji-ngon® (flavor seasoning/Vietnam),
Sazón® (flavor seasoning/Brazil),
Sajiku (menu-specific seasoning/Indonesia), CRISPY FRY (menu-
specific seasoning/Philippines), etc.
Quick Nourishment Knorr® Cup Soup, YumYum® (instant noodles/Thailand), Birdy®
(coffee beverage/Thailand), Birdy® 3in1 (powdered drink/Thailand),
Blendy® brand products (CAFÉ LATORY®, stick coffee, etc.),
MAXIM® brand products, Chyotto Zeitakuna Kohiten® brand
products, various gift sets, office supplies (coffee vending
machines, tea servers), etc.
Solution and
Ingredients
Umami seasoning AJI-NO-MOTO® for foodservice and processed
food manufacturers in Japan,
Seasonings and processed foods for foodservice,
Seasonings for processed foods (savory seasonings, enzyme
ACTIVA®),
Drinks supplied to restaurants, Ingredients for industrial use,
Delicatessen products, Bakery products, Nucleotides,
Sweeteners (aspartame for food processing, PAL SWEET® for
home use, etc.), and others
Frozen Foods Frozen Foods Chinese dumplings (Gyoza, Shoga Gyoza, POT STICKERS, etc.), Cooked rice (THE CHA-HAN, CHICKEN FRIED RICE, YAKITORI CHICKEN FRIED RICE, etc.), Noodles (YAKISOBA, RAMEN, etc.), Desserts (cakes for restaurant and industrial-use, MACARON, etc.), Shumai (THE SHUMAI, etc.), Processed chicken (Yawaraka Wakadori Kara-Age (fried chicken), etc.), and others
Healthcare and
Others
Amino Acids for
Pharmaceuticals and
Foods
Amino acids, culture media, medical foods
Bio-Pharma Services Contract manufacturing services of pharmaceutical intermediates
and active ingredients, sterile products (fill and finish), etc.
Specialty Chemicals Electronic materials (Ajinomoto Build-up Film® (ABF) interlayer
insulating material for semiconductor packages and others),
Functional materials (adhesive PLENSET®),
Magnetic materials (AFTINNOVA® Magnetic Film and others),
activated carbon, release paper, etc.
Others Feed-use amino acids (Lysine, Threonine, Tryptophan, Valine,
AjiPro®-L, etc.),
Fundamental Foods (Glyna®, Amino Aile®),
Functional foods and drinks (amino VITAL®),
Personal Care ingredients (amino acid-based mild surfactant
Amisoft®, Amilite®, amino acid-based humectant Ajidew®, etc.)
16
2) Information by reportable segment
The Group’s sales and earnings by reportable segments are as follows:
Inter-segment sales and transfers are primarily based on transaction prices between third-parties.
1. Other includes the tie-up and other service-related businesses.
2. Common corporate expenses that are not attributed to specific reportable segments are allocated to each
reportable segment based on reasonable criteria. Common corporate expenses mainly relate to the parent
company’s administrative divisions.
First half ended September 30, 2020 (April 1, 2020 to September 30, 2020)
Millions of yen
Reportable segment
Other1 Total Adjust-
ments2
As included
in
condensed
consolidated
financial
statements
Seasonings
and Foods Frozen Foods
Healthcare and
Others
Sales
Sales to third parties 295,386 98,832 110,623 6,539 511,382 — 511,382
Inter-segment sales
and transfers 2,971 726 2,711 18,489 24,897 (24,897) —
Total sales 298,357 99,558 113,335 25,028 536,280 (24,897) 511,382
Share of profit of
associates and joint
ventures
989 — 67 730 1,786 — 1,786
Segment profit or loss
(Business profit or
loss)
47,094 2,656 11,950 239 61,940 — 61,940
Other operating income 6,134
Other operating expense (6,772)
Operating profit 61,302
Financial income 1,585
Financial expense (2,933)
Profit before income taxes 59,954
17
1. Other includes the tie-up and other service-related businesses.
2. Common corporate expenses that are not attributed to specific reportable segments are allocated to each
reportable segment based on reasonable criteria. Common corporate expenses mainly relate to the parent
company’s administrative divisions.
First half ended September 30, 2019 (April 1, 2019 to September 30, 2019)
Millions of yen
Reportable segment
Other1 Total Adjust-
ments2
As included
in
condensed
consolidated
financial
statements
Seasonings
and Foods Frozen Foods
Healthcare and
Others
Sales
Sales to third parties 308,348 103,258 113,575 7,084 532,266 — 532,266
Inter-segment sales
and transfers 2,768 724 2,035 16,166 21,694 (21,694) —
Total sales 311,116 103,982 115,610 23,251 553,960 (21,694) 532,266
Share of profit of
associates and joint
ventures
(3,069) — 141 1,119 (1,808) — (1,808)
Segment profit or loss
(Business profit or
loss)
38,694 1,355 7,150 454 47,654 — 47,654
Other operating income 2,721
Other operating expense (29,616)
Operating profit 20,759
Financial income 3,628
Financial expense (3,395)
Profit before income taxes 20,992